Pathway summary
Data sourcePathways
KEGG pathwaynon small cell lung cancer, HSA05223; natural killer cell mediated cytotoxicity, HSA04650; endometrial cancer, HSA05213; renal cell carcinoma, HSA05211; long term depression, HSA04730; chronic myeloid leukemia, HSA05220; colorectal cancer, HSA05210; prostate cancer, HSA05215; erbb signaling pathway, HSA04012; bladder cancer, HSA05219; insulin signaling pathway, HSA04910; pancreatic cancer, HSA05212; glioma, HSA05214; long term potentiation, HSA04720; acute myeloid leukemia, HSA05221; regulation of actin cytoskeleton, HSA04810; melanoma, HSA05218
NCI pathwayNull
WIKI pathwayIntegrin-mediated Cell Adhesion(Mus musculus), WP6; ESC Pluripotency Pathways(Mus musculus), WP339; Signaling Pathways in Glioblastoma(Homo sapiens), WP2261; Integrated Breast Cancer Pathway(Homo sapiens), WP1984; MAPK Cascade(Mus musculus), WP251; Integrin-mediated Cell Adhesion(Homo sapiens), WP185; ErbB signaling pathway(Mus musculus), WP1261; Focal Adhesion(Homo sapiens), WP306; EGFR1 Signaling Pathway(Mus musculus), WP572; ErbB Signaling Pathway(Homo sapiens), WP673; MAPK Cascade(Homo sapiens), WP422; Focal Adhesion(Mus musculus), WP85